Change in Ratings
(ARO - Get Report)
upgraded at Citigroup to Hold from Sell based on recent decline below target price of $27. Note strong relative September results and see potential for market share gains.
upgraded at Goldman Sachs to Neutral from Sell based on expected resolution of Ohio ratemaking process, defensive positioning and high dividend yield. Price target at $18.
(DWA - Get Report)
upgraded at Jefferies to Buy from Hold. Maintains 2008 EPS estimates of $1.65 and price target of $33.
Advanced Medical Optics
downgraded at Jefferies to Underperform from Buy based on macroeconomic pressures that are likely to affect U.S. and overseas Lasik volumes. Cuts target price to $9 from $28.
upgraded at UBS to Buy from Neutral. Fiscal 2009 EPS estimates lowered to $0.85 from $0.95. Price target lowered to $13 from $13.50.
(INTC - Get Report)
downgraded at ThinkPanmure to Sell from Buy. Sees prior growth drivers fading and multiple macro and company-specific headwinds which should slow growth. Lowered target to $12 from $24.
(MA - Get Report)
downgraded at Deutsche Bank to Hold from Buy based on lowered outlook for global economy. See risk to guidance if conditions continue to deteriorate into recession. Note company's strong position in payment space and ability to protect earnings via pricing power, but prefer
(V - Get Report)
. Price target cut to $200 from $350.
upgraded at Wachovia to Outperform from Underperform. Believe strong balance sheet provides security in current credit environment. See further potential downside in real estate valuation, and PSA could become an acquirer.